In our corporate advisory newsletter, Finbarr Griffin, Head of Corporate Advisory, reflects on a volatile first quarter amid geopolitical instability, surging inflation and concerns over tighter monetary policy.
Gearing up for an IPO
Charlotte Craigie, Director of Corporate Broking
We examine the benefits of an IPO and why it can be a compelling exit strategy.
Case study: Managing the HealthBeacon IPO
David Kearney, Head of Corporate Broking, and Stephen Kane, Director of Corporate Finance
Positioning for growth: Corporate Advisory Newsletter, Q1 2022
In this newsletter, we examine the trends to watch in 2022, our transaction highlights in 2021 and how we managed the HealthBeacon IPO.
Warning: Nothing presented on this website constitutes investment advice as it does not take into account the investment objectives, knowledge and experience or financial situation of any person. You should not act on it in any way and are advised to obtain professional advice suitable to your own individual circumstances. The value of your investment may go down as well as up. You may lose some or all of the money you invest. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities.
Goodbody Stockbrokers UC, trading as Goodbody, is regulated by the Central Bank of Ireland and Goodbody Stockbrokers UC is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Goodbody is a member of Euronext Dublin and the London Stock Exchange. Goodbody is a member of the group of companies headed by AIB Group plc.